Hypertension and Cardiac Damage in Pheochromocytoma and Paraganglioma Patients: a Large-Scale Single-Center Cohort Study

Yang Yu,Chuyun Chen,Lei Meng,Wencong Han,Yan Zhang,Zheng Zhang,Ying Yang
DOI: https://doi.org/10.1186/s12872-024-03936-6
IF: 2.174
2024-01-01
BMC Cardiovascular Disorders
Abstract:Hypertension (HT) is one of the most common manifestations in patients with catecholamine-secreting neuroendocrine tumors. Although the cardiovascular manifestations of these tumors have been described, there have been no large-scale investigations of the profile of HT and changes in cardiac structure and function that occur in patients with pheochromocytomas and paragangliomas (PPGL). In this study, we investigated the prevalence of HT and left ventricular remodeling (LVR) in a cohort of 598 patients who underwent surgery for PPGL at our center between January 2001 and April 2022. Information on demographics, reason for hospitalization, medical history, biochemical parameters, findings on echocardiography, and tumor characteristics were recorded. The LVR index was compared according to whether or not there was a history of HT. The average age was 47.07 ± 15.07 years, and 277 (46.32
What problem does this paper attempt to address?